Business Description
PROCEPT BioRobotics Corp
NAICS : 339112
SIC : 5047
ISIN : US74276L1052
Total Employee Number:
888Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.15 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.22 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 48.6 | |||||
3-Year EBITDA Growth Rate | 4.8 | |||||
3-Year EPS without NRI Growth Rate | 2.9 | |||||
3-Year FCF Growth Rate | 17.5 | |||||
3-Year Book Growth Rate | 13.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 29.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.06 | |||||
9-Day RSI | 1.37 | |||||
14-Day RSI | 4.76 | |||||
3-1 Month Momentum % | -9.8 | |||||
6-1 Month Momentum % | -17.12 | |||||
12-1 Month Momentum % | -59.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.73 | |||||
Quick Ratio | 5.51 | |||||
Cash Ratio | 3.86 | |||||
Days Inventory | 216.65 | |||||
Days Sales Outstanding | 96.23 | |||||
Days Payable | 46.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 | |||||
Shareholder Yield % | 0.18 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.97 | |||||
Operating Margin % | -33.86 | |||||
Net Margin % | -31.82 | |||||
EBITDA Margin % | -28.62 | |||||
FCF Margin % | -24.81 | |||||
OCF Margin % | -21.56 | |||||
ROE % | -27.42 | |||||
ROA % | -20.18 | |||||
ROIC % | -53.57 | |||||
3-Year ROIIC % | -18.23 | |||||
ROC (Joel Greenblatt) % | -63.52 | |||||
ROCE % | -21.92 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.73 | |||||
PB Ratio | 3.52 | |||||
Price-to-Tangible-Book | 3.52 | |||||
EV-to-EBIT | -11.23 | |||||
EV-to-EBITDA | -12.04 | |||||
EV-to-Revenue | 3.45 | |||||
EV-to-Forward-Revenue | 2.62 | |||||
EV-to-FCF | -13.11 | |||||
Price-to-GF-Value | 0.23 | |||||
| Price-to-Net-Current-Asset-Value | 4.24 | |||||
| Price-to-Net-Cash | 11.5 | |||||
Earnings Yield (Greenblatt) % | -8.9 | |||||
FCF Yield % | -6.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PROCEPT BioRobotics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 5,903.414 | ||
| EPS (TTM) (MXN) | -33.208 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 58.76 | ||
| 14-Day RSI | 4.76 | ||
| 14-Day ATR (MXN) | 7.644879 | ||
| 20-Day SMA (MXN) | 457.142 | ||
| 12-1 Month Momentum % | -59.73 | ||
| 52-Week Range (MXN) | 358.45 - 1217.38 | ||
| Shares Outstanding (Mil) | 56.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PROCEPT BioRobotics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PROCEPT BioRobotics Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 16:30 | In 131 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 130 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | In 41 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 40 days | ||
| Guidance call for 2026 | 2026-06-16 13:40 | 479.00 (+0.00%) | ||
| General meeting for 2026 | 2026-06-10 13:00 | 479.00 (+0.00%) | ||
| 46th Annual William Blair Growth Stock Conference | 2026-06-02 13:00 | 490.26 (+0.00%) | ||
| Guidance call for 2026 | 2026-05-12 18:40 | 431.50 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 16:30 | 431.50 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 431.50 (+0.00%) |
Show
Entries
PROCEPT BioRobotics Corp Frequently Asked Questions
What is PROCEPT BioRobotics Corp(MEX:PRCT)'s stock price today?
The current price of MEX:PRCT is MXN358.45. The 52 week high of MEX:PRCT is MXN1217.38 and 52 week low is MXN358.45.
When is next earnings date of PROCEPT BioRobotics Corp(MEX:PRCT)?
The next earnings date of PROCEPT BioRobotics Corp(MEX:PRCT) is 2026-08-06 Est..
Does PROCEPT BioRobotics Corp(MEX:PRCT) pay dividends? If so, how much?
PROCEPT BioRobotics Corp(MEX:PRCT) does not pay dividend.
Press Release
Articles on PROCEPT BioRobotics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers